Trademark: INTERVENN 2216143
Word
INTERVENN
ID
2216143
Trademark Type
Word
Status
Registered: Registered/protected
Application Date
05 October 2021
Registration Date
05 October 2021
Renewal Date
05 October 2031
Owner(s)
Service
Davies Collison Cave Pty Ltd
Goods and Services:
Class 42:
Scientific and medical research services; medical research in the field of oncology, mass spectrometry, and cancer treatment and diagnosis; scientific and medical research services, namely biomarker discovery, target discovery, and drug discovery services; scientific, technological, and data analysis services, namely, chemical, biochemical, and biological in the nature of protein and cellular analysis and use proprietary software to integrate, evaluate, analyze, collect, and report mass spectrometry data; bioanalytical testing services; scientific and technological services, namely, biomarker analysis in the field of mass spectrometry; scientific and technological analyses using mass spectrometry; hosting a database in the field of bioinformatics for medical or scientific research; consulting in the fields of medical research, cancer research, mass spectrometry, clinical trials, biomarkers, biotechnology, laboratory testing, pharmaceutical research, diagnostics, pharmacogenetics, and development, and disease diagnostics, analysis, screening, and treatment; designing and conducting clinical trials for others in the field of disease diagnostics, biomarkers, mass spectrometry, and oncology; providing temporary use of non-downloadable software for medical research, medical diagnostics, mass spectrometry, clinical testing, disease screening, medical treatment, and studying biological molecules and biospecimens; providing temporary use of non-downloadable software for laboratory management, quality assurance, data management, sample analysis and tracking, operating research instruments and medical diagnostic devices, and providing automated monitoring and notifications; chemical research and analysis; consultancy, advisory and information services (including online, interactive, digital and datacasting services) in relation to the foregoing
Scientific and medical research services; medical research in the field of oncology, mass spectrometry, and cancer treatment and diagnosis; scientific and medical research services, namely biomarker discovery, target discovery, and drug discovery services; scientific, technological, and data analysis services, namely, chemical, biochemical, and biological in the nature of protein and cellular analysis and use proprietary software to integrate, evaluate, analyze, collect, and report mass spectrometry data; bioanalytical testing services; scientific and technological services, namely, biomarker analysis in the field of mass spectrometry; scientific and technological analyses using mass spectrometry; hosting a database in the field of bioinformatics for medical or scientific research; consulting in the fields of medical research, cancer research, mass spectrometry, clinical trials, biomarkers, biotechnology, laboratory testing, pharmaceutical research, diagnostics, pharmacogenetics, and development, and disease diagnostics, analysis, screening, and treatment; designing and conducting clinical trials for others in the field of disease diagnostics, biomarkers, mass spectrometry, and oncology; providing temporary use of non-downloadable software for medical research, medical diagnostics, mass spectrometry, clinical testing, disease screening, medical treatment, and studying biological molecules and biospecimens; providing temporary use of non-downloadable software for laboratory management, quality assurance, data management, sample analysis and tracking, operating research instruments and medical diagnostic devices, and providing automated monitoring and notifications; chemical research and analysis; consultancy, advisory and information services (including online, interactive, digital and datacasting services) in relation to the foregoing